2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Tsafta ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Matsakaici
Samar da Sitagliptin Phosphate Monohydrate Matsakaici masu alaƙa:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R) -3-Amino-4- (2,4,5-Trifluoro-Phenyl) -Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Matsakaici CAS 486460-21-3
| Sunan Sinadari | 2,4,5-Trifluorophenylacetic acid |
| Lambar CAS | 209995-38-0 |
| Lambar CAT | Saukewa: RF-PI1191 |
| Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
| Tsarin kwayoyin halitta | Saukewa: C8H5F3O2 |
| Nauyin Kwayoyin Halitta | 190.12 |
| Matsayin narkewa | 121.0 zuwa 125.0 ℃ |
| Solubility | Mai narkewa a cikin methanol |
| Alamar | Ruifu Chemical |
| Abu | Ƙayyadaddun bayanai |
| Bayyanar | Fari zuwa Kashe-Farin Foda |
| Tsarkake / Hanyar Bincike | ≥99.5% (GC) |
| Danshi (KF) | ≤0.50% |
| Rago akan Igniton | ≤0.50% |
| Jimlar ƙazanta | ≤0.50% |
| Matsayin Gwaji | Matsayin Kasuwanci |
| Amfani | Matsakaicin Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.
2,4,5-Trifluorophenylacetic Acid (CAS: 209995-38-0) matsakaici ne na Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9).Ana amfani da Sitagliptin Phosphate (STG) don kula da nau'in DM na 2 saboda yana inganta sarrafa glycemic ta hanyar haɓaka matakan hormones na incretin mai aiki, GLP-1 (peptide-1) da GIP (insulinotropic peptide mai dogaro da glucose).Kunna waɗannan incretins a cikin sel β-pancreatic yana haifar da haɓaka matakan cyclic adenosine monophosphate (cAMP) da calcium intracellular, tare da fitowar insulin mai dogaro da glucose na gaba (2).Wannan maganin hypoglycemic na wani sabon aji ne da ake kira dipeptidyl peptidase IV inhibitors.FDA ta amince da STG a cikin 2006.
